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Abstract
Cutaneous ageing manifests itself as a progressive reduction in maximum function and reserve capacity of
skin tissue. It is not a unique and uniform biological event. Skin comprises three layers: epidermis, dermis
and subcutaneous tissue. Collagen atrophy is a major factor in skin ageing. There is a strong correlation
between skin collagen loss and estrogen deficiency due to the menopause. Skin ageing, especially in the
face, is associated with a progressive increase in extensibility and a reduction in elasticity. With increasing
age, the skin also becomes more fragile and susceptible to trauma, leading to more lacerations and
bruising. Furthermore, wound healing is impaired in older women. Estrogen use after the menopause
increases collagen content, dermal thickness and elasticity, and it decreases the likelihood of senile dry
skin. Large-scale clinical trials are necessary to help make informed recommendations regarding post-
menopausal estrogen use and its role in the prevention of skin ageing.
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Introduction
Consumers refuse to age. Most women want to look as
young as possible, and are constantly searching for any
solution that promises that miracle.
This is what is claimed by beauty industry experts. In
this quest for eternally youthful skin, it was estimated
that, in 2005, $664 million was spent in the US on
anti-ageing skin care products. Indeed, this market
experienced a 33% growth between 2001 and 2005.1
Cutaneous ageing manifests itself as a progressive
reduction in maximum function and reserve capacity of
skin tissues. It is not a unique and uniform biological
event. Factors aggravating the clinical aspects of ageing
include the effects of past or present diseases, as well
as diverse environmental influences and physiological
variations.2 Brincat suggested that there are seven types
of skin ageing, as set out in Table 1.3 This article reviews
the connections between skin ageing, postmenopausal
estrogen deficiency and hormone replacement therapy
(HRT).
Skin physiology
The skin is the largest organ in the body, and is
the primary barrier against pathogen invasion and
dehydration. It comprises a complex mosaic of cells of
diverse embryonic origin that, under normal conditions,
coexist side by side.
Skin consists of three layers: epidermis, dermis and
subcutaneous tissue. It also contains hair follicles, seba-
ceous glands and sweat glands. The epidermis consists
primarily of keratinocytes and melanocytes, and forms
the thin outer layer. The dermis is the deeper layer,
forming the main bulk of the skin. Its function is to pro-
vide a tough matrix to support the blood vessels, nerves
and appendages that are embedded in it.
The fibres present in the dermal connective tissue
are predominantly collagen and elastin.4 Some 80%
of the dry weight of adult skin consists of collagen.
Collagen fibres, produced by fibroblasts, are arranged
parallel to the skin surface. This gives the skin a high
tensile strength and prevents it from being torn by
overstretching. In contrast, elastin constitutes about
5% of the dermis, and provides the skin with elasticity
and resilience.5 Elastin fibres are arranged as a thinly
distributed subepidermal network, and are also produced
by fibroblasts. The dermal connective tissue addition-
ally contains sensory receptors and the supportive
glycosaminogylcans (GAGs).6
Skin quality deteriorates with age due to the syner-
gistic effects of chronological ageing, photo-ageing,
hormonal deficiency and environmental factors (see
Table 1).6 Skin ageing results from a decline in several
Table 1 The seven types of cutaneous ageing3
Ageing types Determining factor
Chronological Passage of time
Genetic Inherited diseases (e.g. premature ageing 
syndromes)
Photo-ageing Ultraviolet and infra-red irradiation
Behavioural Diet, tobacco, alcohol abuse, drug addiction
Catabolic Chronic debilitating diseases (e.g. infections, 
cancers)
Endocrine Dysfunction or ageing of hormone systems 
(e.g. ovaries, testes, thyroid)
Gravitational Gravitational force
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metabolic activities. The dermis undergoes morpho-
logical, physical and chemical changes during ageing.4
Overall, many of the skin’s functions are known to
decline with age (see Box 1).7
The effects of postmenopausal estrogen deficiency
are thought to include: atrophy; decreased collagen and
water content; decreased sebaceous secretions; loss of
elasticity; and manifestations of hyperandrogenism. The
cumulative effects of estrogen deficiency on the skin are
thought to contribute to poor wound healing in older
patients.8 In mice, oophorectomy alone is sufficient to
accelerate skin ageing and increase sensitivity to ultra-
violet radiation.9 This results in further deterioration
of skin quality and increased wrinkling. Thus, estrogen
deficiency may account for the accelerated skin ageing
seen in postmenopausal women.
Effects of ageing and estrogen on 
structural components of the skin
Collagen
The predominant form of collagen found in adult
human skin is type I, followed by type III.10 The genes
for human collagen type I are located on chromosomes
7 and 17. Collagen is synthesized by fibroblasts from
procollagen molecules by the action of neutral endo-
proteases. The fibrils of collagen undergo a series of
post-translational modifications in order to enhance
their stability and tensile strength. In young people,
microscopic examination of collagen from the dermis
of skin areas not exposed to the sun shows thin, wavy,
uniform fibrillar units.
The skin becomes thinner and changes structure and
function with age.11,12 In the elderly, the skin contains
thickened, clumped basophilic collagenous material,
indicating partial degradation of collagen. Collagen
atrophy is a major factor in skin ageing. Studies show
a significant decline in the quantity of dermal collagen
with ageing.
During ageing, there is a decrease in the enzymes
concerned with post-translational processing of col-
lagen. The amounts of hydroxyproline and glycosylated
hydroxylysine in type I collagen decrease with age.
Collagen ageing results from progressive cross-linking
between the collagen molecules. A larger proportion
of the cross-links between collagen molecules become
non-reducible, that is, the number of immature and
reducible cross-links decrease with age. The molar ratio
of glycosylated hydroxylysine residues to unsubstituted
hydroxylysine residues has been found to increase with
age. There is a reduction in the number of fibroblasts
that synthesize collagen and vessels that supply the skin.
This leads to an increase in laxity and hence wrinkles.4
The exact effect of estrogen on collagen integrity is
still unclear.8 Anabolic steroids have been shown to
increase collagen synthesis by human dermal fibroblasts.
In rats, estrogen has been shown to inhibit collagen deg-
radation. However, estrogens have no stimulatory effect
on procollagen synthesis in cultured human cells.13
There is a strong correlation between skin collagen
loss and estrogen deficiency due to menopause.8,14–18 As
much as 30% of skin collagen (both type I and type III)
is lost in the first five years after the menopause. Total
collagen content declines by an average of 2.1% per
postmenopausal year over 15 years. This decrease in skin
collagen correlates with age-related decreases in bone
mineral density. This is consistent with the presence of
type I collagen in bone.19 Although one study found
a closer correlation between collagen loss and chrono-
logical age than between skin collagen loss and time
since menopause,15 the study participants were between
40 and 55 years of age and had recently undergone
surgical menopause. Consequently, the participants may
not have been estrogen deficient sufficiently long for
the correlation to become apparent.18 Moreover, one
year after the menopause there was a more pronounced
reduction in skin collagen content.18
The decline in skin collagen content can be prevented
by administering estrogen.8,18 A beneficial effect of
subcutaneous, topical or oral estrogens has been demon-
strated on skin collagen content.20–23 The extent of the
estrogen-induced increase in collagen content varies
with the route of administration, dose and duration
of hormone treatment. As there are differences in the
methods employed to assess collagen levels, results
between studies are often not comparable.8 The increase
in collagen with estrogen is proportional to baseline col-
lagen levels. However, one study observed no change in
collagen levels of postmenopausal women following one
year of HRT.24 This can be explained by the fact that,
given the short time since menopause, the amount and
synthesis of collagen may not yet have fallen.25 Collagen
levels and metabolism do not change immediately after
the menopause.14
Elastin
Like collagen, elastin is a fibre-forming functional
protein. Elastin fibres are closely linked and interwoven
with the collagen fibrils so that they can recoil after
transient stretching and are prevented from over-
stretching. Women with a premature menopause have
accelerated degenerative changes in dermal elastic
fibres.6 Histological studies demonstrate that topical
estrogen can increase the number and thickness of skin
elastic fibres.26 Clinical trials, however, demonstrated no
observable improvement in elastin fibre content from
baseline with systemic estrogen therapy,23,24,27 although
these studies were small, short (6 months) or treated
women shortly after the onset of menopause.
Water
Healthy skin has a substantial water content, which is
determined by cutaneous evaporation and epidermal
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hydration.8 Transepidermal water flux decreases with
age.11 There are minor quantities of various glycos-
aminoglycans (including versican and heparan sulfate)
in the dermis, which are closely associated with skin
collagen. These glycosaminoglycans have a high water-
binding capability, and are essential for normal skin
hydration. Total dermal glycosaminoglycan content
decreases significantly with age.4 It has been postulated
that collagen and glycosaminoglycans may interact to
produce the age-related changes in the properties of
collagen. It is possible that hydration of the dermis,
influenced by glycosaminoglycans, may be more
important than the extent of collagen cross-linking.
Dry skin is one of the commonest dermatological
conditions in older women.28 An epidemiological survey
of 3875 postmenopausal women aged 40 years and
over found that 36.2% had dry skin. Estrogen use was
associated with a statistically significant decrease in the
likelihood of senile dry skin (odds ratio 0.76, 95% CI
0.60–0.97).29 These positive effects may be related to
estrogen-stimulated increases in mucopolysaccharides
and hyaluronic acid levels in skin, which correlate with
an increased dermal water content.11 These increases
may also lead to an increase in skin thickness.
Sebaceous glands and hair
Sebum secretion decreases with age. Overall, there is a
38% increase in sebum production in postmenopausal
women taking HRT, when compared with controls.
Combined HRT increases skin surface lipids.30,31
Possible changes in postmenopausal women include
an increase in facial hair, and a decrease in body and/or
pubic hair. The onset of menopause can lead to a diffuse
or an androgenic alopecia.32–34 Another type of hair loss
seen with ageing is frontal fibrosing alopecia, which is a
variant of lichen planopilaris. The latter has been associ-
ated with menopause; however, hair loss persists despite
hormone treatment.35
Effects of ageing and estrogen on 
physical characteristics of the skin
Skin thickness
There is an increase in skin thickness up to the age of
35–49 years, followed by an age-related thinning.8 For
the initial 15–18 postmenopausal years, the decrease
in skin thickness accelerates, with as much as a 1.13%
annual decline.14,16 The thinning effect is due to
decreases in collagen, water and glycosaminoglycans.8
There is a high incidence of thin skin in osteoporotic
women and there is a strong correlation between skin
thickness, collagen content and bone density in post-
menopausal women.19 Most clinical trials have shown
that postmenopausal women who take HRT have greater
skin thickness than non-users.36–38
Elasticity
Skin ageing, especially in the face, is associated with a
progressive increase in extensibility and a reduction in
skin elasticity.8 Skin elasticity declines 0.55% per year
after the menopause. Twelve months of HRT has been
found to increase elasticity by 5.2%.39 HRT delays the
deterioration in the extensibility of the skin, slowing
the progress of cutaneous slackening secondary to
menopause.31,40
Wrinkles
The loss of connective tissue in cutaneous ageing
results in increased distensibility and loss of skin tone,
leading to a progressive deepening of facial creases and
wrinkling.8 In untreated perimenopausal women, there
is a rapid increase in skin extensibility, as detected by
computerized measurements of skin deformability.
The mechanical properties of the skin improve with
estrogen.41 Facial wrinkling improves with estrogens but
worsens with smoking.40,42 However, few clinical studies
have specifically examined HRT and facial wrinkling,
probably owing to technical challenges in quantifica-
tion.8
Blood flow
The dermis and epidermis are nourished by arterioles
and capillaries that pass upwards from the subcutaneous
layer. The integrity of the structure and function of
capillary blood vessels is important for healthy skin.
There is a rich capillary network in the dermal papillae,
which is responsible for the menopausal flush.43
Core temperature haemostasis is maintained by the
cutaneous circulation. Peripheral microcirculation at the
level of the nail-fold capillaries decreases significantly
during the menopause.44 After 6–12 months of HRT,
capillary blood flow increases in the nail-fold by as
much as 20–30%.44 The endothelium-dependent and
endothelium-independent vascular reactivity in the
cutaneous microcirculation improves substantially in
postmenopausal women who receive estrogen.45
Wound healing
With increasing age, the skin becomes more fragile and
susceptible to trauma, leading to more lacerations and
bruising. Older women have been shown to heal less
well, possibly because they have low levels of trans-
forming growth factor (TGF)-B.8 Venous ulcers and
pressure sores are among the chronic wounds commonly
suffered by the elderly. These cause significant suffering
and cost, thus imposing a burden for patients and
physicians alike.46
Cutaneous wound healing involves vasculariz-
ation, granulation, collagen deposition and re-
epithelialization.47 The effect of estrogen levels on
the stages of wound healing is still unclear, because of
contradictory findings in animal studies.8 In humans,
estrogen has been shown to induce TGF-B secretion by
dermal fibroblasts, and this can enhance the rate and
quality of wound healing.48
Effects on sexuality
Skin changes can affect psychosexual function.49,50
The appearance of wrinkles and skin sagging can lower
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self-esteem. Altered peripheral nerve function, especially
in the genital area, can lead to reduced libido and
dyspareunia.50
Conclusions
Chronological age, environmental factors and the
menopause have a profound impact on skin. Estrogen
treatment in postmenopausal women increases dermal
thickness, collagen content and elasticity. However,
large-scale clinical trials are necessary to help provide
the basis on which to make informed recommendations
regarding postmenopausal estrogen use and its role in
the prevention of skin ageing.
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